Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics

通过 Nrf2 和表观遗传学使用植物化学物质预防皮肤癌

基本信息

  • 批准号:
    9207083
  • 负责人:
  • 金额:
    $ 35.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-01-13 至 2020-12-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Non-melanoma skin cancers are the most common types of cancers in the United States, with over 1 million new cases per year, while increasing exposure to sunlight (UV) and environmental carcinogens appear to be the major causative factors. The long term goal of this application is to develop a safe and effective strategy using relatively non-toxic dietary cancer chemopreventive compounds to prevent skin cancer. The rationale for these studies is based on investigation from our laboratory and others, showing that: (1) Sulforaphane (SFN) presents abundantly in these berries and crucifers, respectively, strongly inhibits skin carcinogenesis in various mouse models in vivo; (2) Skin carcinogenesis is greatly enhanced in knockouts of Nrf2, a transcription factor critical in mediating anti-oxidative stress/inflammatory responses, and, importantly, SFN has no cancer protective effect in these Nrf2(-/-) mice; (3) Nrf2 and Nrf2-targeted HO-1 expression is decreased in skin tumors in Nrf2(+/+) mice; (4) Enhanced expression of c-Myc, Bcl-2, cyclin D1, beta-catenin, VEGF, Cox-2, and Bax is seen in all skin tumors; (5) UVB enhanced expression of inflammatory biomarkers in the skin of Nrf2(-/-) mice is substantially decreased compared with Nrf2(+/+) mice; (6) SFN induces cellular antioxidant proteins in MEFs (mouse embryonic fibroblast) and MEKs (mouse epidermal keratinocytes) of Nrf2 (+/+) but not of Nrf2 (- /-); (7) SFN blocks TPA-induced ear inflammation in C57BL/6J mice and not in Nrf2(-/-) mice; (8) Ursolic acid (UA), a natural triterpenoid with potent anti-inflammatory and cancer preventive activities inhibits TPA-induced ear edema and tumor promotion; (9) Increasing evidence suggests that epigenetics plays an important role in cancer development and progression including non-melanoma skin cancer; both UA and SFN modify CpG methylation of Nrf2 in JB6 mouse epidermal cell line; (10) Significant difference are observed in global DNA methylation profiles between DMBA/TPA papilloma vs normal skin and UVB-induced skin tumor vs non- irradiated skin analyzed by MeDIP-Seq analysis; and (11) UA and SFN inhibit TPA-induced JB6 transformation in soft agar. Based on the results summarized above we hypothesize that UA and SFN prevent skin carcinogenesis by altering epigenetic modifications with 3 specific aims: (1) To investigate the epigenetic events during in vivo skin cancer development and progression in B[a]P/TPA-induced skin carcinogenesis in Nrf2(+/+) vs Nrf2(-/-) C57BL6 mice, UVB-induced skin tumorigenesis in SKH-1 mice, and the cancer preventive efficacy coupled with epigenetic changes of UA and SFN; (2) To examine the epigenetic changes during transformation in vitro of mouse epidermal JB6 and human keratinocyte HaCaT cells and the effect of UA and SFN on these epigenetic changes; (3) To elucidate the molecular mechanisms involved in the epigenetic regulation of inflammatory/oxidative stress genes identified in Aims 1 and 2 by UA and SFN in mouse epidermal JB6 and human keratinocyte HaCaT cells. This study will advance our knowledge in developing better chemopreventive compounds for cancer chemoprevention clinical trials in skin cancer.
 描述(通过应用程序提供):非黑色素瘤皮肤癌是美国最常见的癌症类型,每年有超过100万例新病例,同时增加对阳光(UV)的暴露(UV)和环境致癌物似乎是主要的基因制造商。该应用的长期目标是使用相对无毒的饮食癌症化合物制定安全有效的策略,以预防皮肤癌。这些研究的基本原理是基于我们实验室和其他研究的投资,表明:(1)Sulforaphane(SFN)分别在这些浆果和十字架中表现出来,在体内各种小鼠模型中都强烈抑制皮肤致癌作用; (2)在NRF2的敲除中,皮肤致癌作用得到了极大的增强,NRF2的转录因子在介导抗氧化应激/炎症反应中至关重要,并且重要的是,SFN在这些NRF2( - / - )小鼠中没有癌症保护作用; (3)NRF2(+/+)小鼠的皮肤肿瘤中NRF2和NRF2靶向的HO-1表达降低; (4)在所有皮肤肿瘤中都可以看到C-Myc,Bcl-2,Cyclin D1,Beta-catenin,VEGF,COX-2和BAX的表达; (5)与NRF2(+/+)小鼠相比,NRF2( - / - )小鼠皮肤中炎症生物标志物的表达增强了; (6)SFN在NRF2(+ /+)的MEF(小鼠胚胎成纤维细胞)和MEK(小鼠表皮角膜细胞)中诱导细胞抗氧化剂蛋白,但不是NRF2( - / - ); (7)SFN阻断了C57BL/6J小鼠中TPA诱导的耳朵感染,而不是NRF2( - / - )小鼠; (8)乌斯卡酸(UA),一种具有潜在抗炎和癌症预防活性的天然三萜类化合物,抑制了TPA诱导的耳水肿和肿瘤促进; (9)越来越多的证据表明,表观遗传学在包括非黑色素瘤皮肤癌的癌症发展和进展中起着重要作用。 UA和SFN均修饰JB6小鼠表皮细胞系中NRF2的CpG甲基化; (10)在DMBA/TPA乳头状瘤与正常皮肤与UVB诱导的皮肤肿瘤与通过MEDIP-SEQ分析分析的非辐射的皮肤之间的全球DNA甲基化谱图中观察到显着差异; (11)UA和SFN抑制TPA诱导的软琼脂中的JB6转化。根据上述总结的结果,我们假设UA和SFN通过以3个特定目的改变表观遗传学修饰来防止皮肤致癌作用:(1)研究B [A] P/TPA诱导的NRF2(+/+)NRF2(+/+/+)的B/TPA诱导的B/TPA诱导皮肤癌的B [A] P/TPA诱导的皮肤癌的表观遗传事件( UVB诱导的SKH-1小鼠皮肤肿瘤发生,癌症预防有效性以及UA和SFN的表观遗传变化; (2)检查小鼠表皮JB6和人角质形成细胞细胞的体外转化过程中的表观遗传变化以及UA和SFN对这些表观遗传变化的影响; (3)阐明在小鼠表皮JB6和人角质形成型HACAT细胞中,UA和SFN在AIM 1和2中鉴定出的AIM 1和2中鉴定在AIM 1和2中的炎性/氧化应激基因的分子机制。这项研究将促进我们在开发更好的化学预防化合物中用于皮肤癌的化学预防临床试验的知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ah-Ng Tony Kong其他文献

Potent Inhibitory Effect of δ?Tocopherol on Prostate Cancer Cellsbr /Cultured in Vitro and Grown As Xenograft Tumors in Vivo
生育酚对体外培养的前列腺癌细胞和体内异种移植肿瘤的有效抑制作用
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hong Wang;Zhi Yun Du;Dongli Li;Kun Zhang;Ah-Ng Tony Kong;Robert S. DiPaola;Chung S. Yang;Allan H. Conney;Xi Zheng
  • 通讯作者:
    Xi Zheng
Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction.
  • DOI:
    10.1016/j.bmcl.2013.03.013
  • 发表时间:
    2013-05-15
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Hu, Longqin;Magesh, Sadagopan;Chen, Lin;Wang, Lili;Lewis, Timothy A.;Chen, Yu;Khodier, Carol;Inoyama, Daigo;Beamer, Lesa J.;Emge, Thomas J.;Shen, Jian;Kerrigan, John E.;Ah-Ng Tony Kong;Dandapani, Sivaraman;Palmer, Michelle;Schreiber, Stuart L.;Munoz, Benito
  • 通讯作者:
    Munoz, Benito

Ah-Ng Tony Kong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ah-Ng Tony Kong', 18)}}的其他基金

Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
  • 批准号:
    9120455
  • 财政年份:
    2015
  • 资助金额:
    $ 35.46万
  • 项目类别:
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
  • 批准号:
    9136770
  • 财政年份:
    2015
  • 资助金额:
    $ 35.46万
  • 项目类别:
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
  • 批准号:
    9761462
  • 财政年份:
    2015
  • 资助金额:
    $ 35.46万
  • 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
  • 批准号:
    8234574
  • 财政年份:
    2012
  • 资助金额:
    $ 35.46万
  • 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
  • 批准号:
    8722448
  • 财政年份:
    2012
  • 资助金额:
    $ 35.46万
  • 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
  • 批准号:
    8913687
  • 财政年份:
    2012
  • 资助金额:
    $ 35.46万
  • 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
  • 批准号:
    9122322
  • 财政年份:
    2012
  • 资助金额:
    $ 35.46万
  • 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
  • 批准号:
    8538296
  • 财政年份:
    2012
  • 资助金额:
    $ 35.46万
  • 项目类别:
Prostate cancer prevention by tocopherols
通过生育酚预防前列腺癌
  • 批准号:
    8228174
  • 财政年份:
    2011
  • 资助金额:
    $ 35.46万
  • 项目类别:
Prostate cancer prevention by tocopherols
通过生育酚预防前列腺癌
  • 批准号:
    8055207
  • 财政年份:
    2011
  • 资助金额:
    $ 35.46万
  • 项目类别:

相似国自然基金

靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
  • 批准号:
    82273824
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
  • 批准号:
    82204218
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
  • 批准号:
    82103973
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Peptide-Modified Sulfonated Styrene Block Copolymers for Vascular Applications
用于血管应用的肽改性磺化苯乙烯嵌段共聚物
  • 批准号:
    7393608
  • 财政年份:
    2008
  • 资助金额:
    $ 35.46万
  • 项目类别:
REGULATION OF MULTIDRUG RESISTANCE IN S AUREUS
金黄色葡萄球菌多重耐药性的调控
  • 批准号:
    7610362
  • 财政年份:
    2007
  • 资助金额:
    $ 35.46万
  • 项目类别:
Airway Epithelial Adaptation to Infectious Stimuli
气道上皮对感染刺激的适应
  • 批准号:
    7214764
  • 财政年份:
    2005
  • 资助金额:
    $ 35.46万
  • 项目类别:
Airway Epithelial Adaptation to Infectious Stimuli
气道上皮对感染刺激的适应
  • 批准号:
    7392300
  • 财政年份:
    2005
  • 资助金额:
    $ 35.46万
  • 项目类别:
Peroxisome Proliferator Activated Receptors in Lung Cancer
肺癌中的过氧化物酶体增殖物激活受体
  • 批准号:
    7409657
  • 财政年份:
    2004
  • 资助金额:
    $ 35.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了